This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2013 Jan 16;309(3):239-40.

doi: 10.1001/jama.2012.168095.

Mega-trials for blockbusters

John P A Ioannidis¹

Affiliations

PMID: 23321760
DOI: 10.1001/jama.2012.168095

Mega-trials for blockbusters

John P A Ioannidis. JAMA. 2013.

. 2013 Jan 16;309(3):239-40.

doi: 10.1001/jama.2012.168095.

Author

John P A Ioannidis¹

Affiliation

¹ Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA. jioannid@stanford.edu

PMID: 23321760
DOI: 10.1001/jama.2012.168095

No abstract available

PubMed Disclaimer

Comment in

Mega-randomized clinical trials for blockbuster drugs.
Landy DC, Hecht EM. Landy DC, et al. JAMA. 2013 Apr 24;309(16):1682-3. doi: 10.1001/jama.2013.2736. JAMA. 2013. PMID: 23613068 No abstract available.
Mega-randomized clinical trials for blockbuster drugs--reply.
Ioannidis JP. Ioannidis JP. JAMA. 2013 Apr 24;309(16):1683. doi: 10.1001/jama.2013.2742. JAMA. 2013. PMID: 23613069 No abstract available.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations